Physician profile
Amy N Hendrix
NPI 1720288228
$674.41
in general payments reported to CMS, 2019-2025
19 companies · $200 in 2025
The $200 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $52.42 · 2020: $25.89 · 2021: $20.26 · 2022: $56.48 · 2023: $91.19 · 2024: $229 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $519.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $519.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $93.88 | 2024-2025 | Zurzuvae |
| Pfizer INC. | $77.28 | 2023-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $76.25 | 2021-2025 | |
| Abbott Laboratories | $70.78 | 2022-2024 | Freestyle Libre 3 |
| Sumitomo Pharma America, INC. | $57.30 | 2024-2025 | Myfembree |
| Organon LLC | $47.57 | 2022-2025 | Nexplanon |
| Minerva Surgical, INC | $40.19 | 2019-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.30 | 2024-2025 | Xifaxan, Trulance |
| Abbvie INC. | $25.89 | 2020 | |
| Verona Pharma, INC. | $21.76 | 2025 | Ohtuvayre |
| Astellas Pharma US INC | $18.33 | 2025 | Veozah |
| Amgen INC. | $17.49 | 2019 | |
| Novo Nordisk INC | $16.30 | 2025 | Ozempic |
| Astrazeneca Pharmaceuticals LP | $15.89 | 2024 | Airsupra |
| Journey Medical Corporation | $15.81 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $13.67 | 2025 | The Cologuard Plus Collection Kit |
| Glaxosmithkline, LLC. | $13.66 | 2025 | Arexvy, Shingrix |
| Daiichi Sankyo INC. | $12.11 | 2019 | |
| Avion Pharmaceuticals | $10.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Hendrix listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.